Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC388282 Inhibitors

The term LOC388282 Inhibitors refers to a class of chemical compounds specifically designed to modulate the activity of LOC388282, a molecular target whose detailed functions and biological roles may be subject to ongoing research. LOC388282 itself likely plays a crucial role in various cellular processes, and inhibitors within this class aim to interfere with its normal function. These inhibitors are meticulously crafted through medicinal chemistry approaches, involving the synthesis and optimization of chemical structures to achieve a high level of selectivity and potency in inhibiting LOC388282.

The chemical structures of LOC388282 Inhibitors are characterized by specific molecular features that facilitate binding to the target site on LOC388282, disrupting its normal biochemical activities. The development of these inhibitors often involves a combination of computational modeling, structure-activity relationship studies, and iterative synthesis to fine-tune their properties. Researchers focus on understanding the three-dimensional structure of LOC388282 and the binding interactions between the inhibitor and the target to enhance the efficacy of the inhibitors. The detailed investigation of LOC388282 Inhibitors is pivotal not only for understanding the biological functions of LOC388282 but also for potential applications in various research fields.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound is a DNA methyltransferase inhibitor. It could hypothetically inhibit LOC388282 by reducing methylation levels, leading to increased gene transcription.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Similar to 5-azacytidine, decitabine may inhibit DNA methyltransferases, potentially leading to demethylation and activation of gene expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor. It could hypothetically increase acetylation of histones, leading to a more open chromatin structure and potentially affecting LOC388282 expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

As another histone deacetylase inhibitor, vorinostat may change the chromatin structure and thereby potentially influence the expression of LOC388282.

Panobinostat

404950-80-7sc-208148
10 mg
$196.00
9
(1)

Panobinostat inhibits histone deacetylases, which might lead to altered expression of many genes, possibly including LOC388282.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

This compound intercalates into DNA and inhibits RNA polymerase, which could lead to a decrease in gene expression, including potentially LOC388282.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin binds to the bacterial RNA polymerase, and while it's specific to bacteria, if LOC388282 has bacterial origins, it could hypothetically inhibit its expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin is an inhibitor of RNA polymerase II in eukaryotes and could potentially reduce the expression of LOC388282 by inhibiting mRNA synthesis.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A binds to DNA and inhibits RNA synthesis, which could potentially affect the expression of LOC388282.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine intercalates into DNA. Though it is mainly used for other applications, its DNA-binding property might hypothetically influence the expression of certain genes.